Stock 301166 SHANGHAI UNIVERSAL BIOTECH CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Shanghai Universal Biotech Co.,Ltd.

Equities

301166

CNE100005709

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-15 EDT 		5-day change 1st Jan Change
30.67 CNY -0.74% Intraday chart for Shanghai Universal Biotech Co.,Ltd. -16.86% -20.17%
04-26 Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 Shanghai Universal Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 8,927 3,963 3,330
Enterprise Value (EV) 1 7,058 2,382 1,877
P/E ratio 62 x 37.2 x 81.7 x
Yield 0.49% 1.97% 1.22%
Capitalization / Revenue 8.04 x 3.32 x 2.72 x
EV / Revenue 6.36 x 1.99 x 1.53 x
EV / EBITDA 54.3 x 26 x 541 x
EV / FCF 225 x -10 x -157 x
FCF Yield 0.44% -9.99% -0.64%
Price to Book 4.27 x 1.84 x 1.57 x
Nbr of stocks (in thousands) 86,667 86,667 86,667
Reference price 2 103.0 45.73 38.42
Announcement Date 4/24/22 4/26/23 4/22/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 604 786.9 849.1 1,110 1,195 1,226
EBITDA 1 50.91 74.19 92.34 130.1 91.59 3.467
EBIT 1 47.66 70.02 86.12 125.3 85.77 -6.208
Operating Margin 7.89% 8.9% 10.14% 11.29% 7.18% -0.51%
Earnings before Tax (EBT) 1 50.53 73.6 95.74 137.7 128.5 35.48
Net income 1 39.87 57.94 76.49 108.7 106.5 40.32
Net margin 6.6% 7.36% 9.01% 9.8% 8.91% 3.29%
EPS 2 0.6600 0.9300 1.180 1.660 1.230 0.4700
Free Cash Flow 1 11.89 -43.4 64.14 31.39 -238.1 -11.95
FCF margin 1.97% -5.52% 7.55% 2.83% -19.92% -0.98%
FCF Conversion (EBITDA) 23.36% - 69.46% 24.13% - -
FCF Conversion (Net income) 29.83% - 83.85% 28.87% - -
Dividend per Share - - - 0.5000 0.9000 0.4700
Announcement Date 1/6/21 1/6/21 4/24/22 4/24/22 4/26/23 4/22/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 108 156 241 1,868 1,581 1,453
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 11.9 -43.4 64.1 31.4 -238 -12
ROE (net income / shareholders' equity) 23.3% 22.3% 20.8% 8.72% 5.02% 1.89%
ROA (Net income/ Total Assets) 10.4% 10.3% 9.83% 5.39% 2.24% -0.16%
Assets 1 384.3 562.3 778.5 2,016 4,759 -25,342
Book Value Per Share 2 3.170 5.070 6.230 24.10 24.90 24.40
Cash Flow per Share 2 0.5600 2.350 3.860 21.60 8.450 4.780
Capex 1 6.31 5.47 4.95 14.3 61.5 63.2
Capex / Sales 1.04% 0.69% 0.58% 1.29% 5.15% 5.15%
Announcement Date 1/6/21 1/6/21 4/24/22 4/24/22 4/26/23 4/22/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SHANGHAI UNIVERSAL BIOTECH CO.,LTD. Stock Shanghai Universal Biotech Co.,Ltd.
-20.17% 371M
MCKESSON CORPORATION Stock McKesson Corporation
+20.04% 71.69B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-2.10% 23.65B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+9.05% 9.01B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+10.34% 8.64B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-19.68% 8.15B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+13.68% 5.33B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+14.69% 4.35B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.04% 4.1B
GALENICA AG Stock Galenica AG
-2.27% 3.94B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 301166 Stock
  4. Financials Shanghai Universal Biotech Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW